| Common Stock |
2,643,705 |
$13,218,525 |
$5.00 |
21 Jun 2023 |
Directly held by Bios Fund III QP, LP |
|
|
| Common Stock |
1,023,442 |
$5,117,210 |
$5.00 |
21 Jun 2023 |
Directly held by Bios Fund II QP, LP |
|
|
| Common Stock |
799,467 |
$3,997,335 |
$5.00 |
21 Jun 2023 |
Directly held by Bios Fund I, LP |
|
|
| Common Stock |
467,613 |
$2,338,065 |
$5.00 |
21 Jun 2023 |
Directly held by Bios Fund I QP, LP |
|
|
| Common Stock |
436,173 |
$2,180,865 |
$5.00 |
21 Jun 2023 |
Directly held by Bios Azitra Co-Invest I, LP |
|
|
| Common Stock |
426,944 |
$2,134,720 |
$5.00 |
21 Jun 2023 |
Directly held by Bios Fund III NT, LP |
|
|
| Common Stock |
404,767 |
$2,023,835 |
$5.00 |
21 Jun 2023 |
Directly held by Bios Fund III, LP |
|
|
| Common Stock |
313,250 |
$1,566,250 |
$5.00 |
21 Jun 2023 |
Directly held by Bios Fund II, LP |
|
|
| Common Stock |
137,000 |
$685,000 |
$5.00 |
21 Jun 2023 |
Directly held by Bios Fund II NT, LP |
|
|
| Common Stock |
135,808 |
$679,040 |
$5.00 |
21 Jun 2023 |
Direct |
|
|
| Common Stock |
13,106 |
$65,530 |
$5.00 |
21 Jun 2023 |
Directly held by KF Legacy Trust |
|
|
| Common Stock |
13,106 |
$65,530 |
$5.00 |
21 Jun 2023 |
Directly held by MF Legacy Trust |
|
|
| Convertible Notes |
0 |
|
|
21 Jun 2023 |
Directly held by Bios Fund III, LP |
|
|
| Convertible Notes |
0 |
|
|
21 Jun 2023 |
Directly held by Bios Fund III NT, LP |
|
|
| Convertible Notes |
0 |
|
|
21 Jun 2023 |
Directly held by Bios Fund III QP, LP |
|
|
| Series A-1 Convertible Preferred Stock |
0 |
|
|
21 Jun 2023 |
Directly held by Bios Azitra Co-Invest I, LP |
Common Stock |
|
| Series A-1 Convertible Preferred Stock |
0 |
|
|
21 Jun 2023 |
Directly held by Bios Fund II, LP |
Common Stock |
|
| Series A-1 Convertible Preferred Stock |
0 |
|
|
21 Jun 2023 |
Directly held by Bios Fund II NT, LP |
Common Stock |
|
| Series A-1 Convertible Preferred Stock |
0 |
|
|
21 Jun 2023 |
Directly held by Bios Fund II QP, LP |
Common Stock |
|
| Series A Convertible Preferred Stock |
0 |
|
|
21 Jun 2023 |
Directly held by Bios Fund I, LP |
Common Stock |
|
| Series A Convertible Preferred Stock |
0 |
|
|
21 Jun 2023 |
Directly held by Bios Fund I QP, LP |
Common Stock |
|
| Series B Convertible Preferred Stock |
0 |
|
|
21 Jun 2023 |
Directly held by Bios Fund III, LP |
Common Stock |
|
| Series B Convertible Preferred Stock |
0 |
|
|
21 Jun 2023 |
Directly held by Bios Fund III NT, LP |
Common Stock |
|
| Series B Convertible Preferred Stock |
0 |
|
|
21 Jun 2023 |
Directly held by Bios Fund III QP, LP |
Common Stock |
|
| Series B Convertible Preferred Stock |
0 |
|
|
21 Jun 2023 |
Directly held by Bios Fund II, LP |
Common Stock |
|
| Series B Convertible Preferred Stock |
0 |
|
|
21 Jun 2023 |
Directly held by Bios Fund II NT, LP |
Common Stock |
|
| Series B Convertible Preferred Stock |
0 |
|
|
21 Jun 2023 |
Directly held by Bios Fund II QP, LP |
Common Stock |
|